PEBP1 and nonpapillary renal cell carcinoma: In order to validate the significantly differential urine excretion of RKIP between ccRCC and PCa patients observed by SELDI profiling (Figure 3A and 3B), we carried out immunoblotting analysis on urine samples of 8 patients from each group.